Rivaroxaban contraindications: Difference between revisions

Revision as of 18:01, 21 July 2014

Redirect to:

@@ Line 1: / Line 1: @@
-__NOTOC__
+#REDIRECT [[Rivaroxaban#Contraindications]]
-{{Rivaroxaban}}
-{{CMG}}; {{AE}} {{AZ}}
-==Contraindications==
+[[Category: Cardiovascular Drugs]]
-XARELTO is contraindicated in patients with:
+[[Category: Drug]]
-*active pathological bleeding [see [[Rivaroxaban warnings and precautions |Warnings and Precautions]] (5.2)]
-*severe hypersensitivity reaction to XARELTO (e.g., [[anaphylactic reactions]]) [see [[Rivaroxaban adverse reactions |Adverse Reactions]] (6.2)] <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = XARELTO (RIVAROXABAN) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] |url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10db92f9-2300-4a80-836b-673e1ae91610 | publisher =  | date =  | accessdate = }}</ref>
-==References==
-{{Reflist}}
-{{FDA}}
-[[Category:Drugs]]